EUROPEAN MEDICINE REGULATORS OPPOSE FREE ACCESS TO CLINICAL TRIAL DATA
April 1st, 2012
BY KEITH NUTHALL
A PAPER written by key European Union (EU) regulators has argued against releasing full datasets of clinical trials, arguing egotistical researchers might scan them for potential problems, generating health scares. The potentially controversial claims are made by the European Medicines Agency's (EMA) senior medical officer Hans-Georg Eichler, executive director Guido Rasi, and officials from the national pharmaceutical regulators in Britain, France and the Netherlands. Their paper, published in the PLoS Medicine journal, argues that scientists ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.